Latest Aggregates News

Group One Capital delivered a sharp revenue increase and remained profitable in FY2026 as structured finance emerged as a material new income stream. The opportunity is significant, but future fee receipts remain tied to project settlements, refinancing and contractual conditions.

Pioneer Minerals has warned of a material uncertainty over its ability to continue as a going concern after closing FY2026 with just A$80,302 in cash. The company is relying on a proposed A$2.5 million capital raising while pushing its Idaho tungsten-gold-gallium project towards maiden drilling.

Duxton Farms has warned of a material uncertainty around its ability to continue as a going concern after a merger-driven loss, sharply higher borrowings and heavy cash outflows. The agricultural group is relying on asset sales, cost reductions and fresh funding while it tries to shift from mature broadacre assets into longer-dated development projects.

Pantera Minerals is seeking a low-cost foothold in Western Australia’s Albany Fraser Orogen through the proposed acquisition of the 470km² Corona Gold Project. The tenure carries an 8km historical gold anomaly and untested auger targets, but the evidence remains reconnaissance-stage and the transaction terms contain a share-count discrepancy that investors will want clarified.

IperionX has moved its Virginia titanium operation into 24/7 production, lifting nameplate powder capacity to about 200 tonnes a year while commissioning equipment aimed at higher-value components. The progress came alongside a US$66.8 million annual loss, US$63.5 million of operating and investing cash outflows, and continued reliance on government support, customer qualification and future capital.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

ABx Group has lodged a prospectus for a fully underwritten $2 million share purchase plan, forming part of a broader $4.1 million capital raising for its Deep Leads rare earths project and ALCORE pilot plant. The offer gives eligible shareholders discounted shares and options, but leaves the final price unknown until after applications close and remains subject to shareholder approval.

Comvita shareholders will vote on a contested-looking board agenda featuring five director elections, three proposed removals and a 39.3% increase in total director remuneration. The proxy form provides no explanation for the removals, leaving the 28 October meeting as the key test of shareholder support.

Zeus Resources has reported high-grade surface antimony results in Morocco while moving to acquire a copper-gold project in Mauritania. The exploration story is advancing, but the audited accounts flag a material uncertainty over the company’s ability to continue as a going concern.

Sonic Healthcare delivered a strong FY2026, with underlying net profit up 17% to A$621 million and dividends rising to A$1.08 per share. The next test is whether US efficiencies, LADR synergies and organic growth can offset Swiss fee cuts, a delayed UK contract ramp-up and heavier investment demands.

NoviqTech has secured binding commitments for a $1.805 million share placement, but the raise cannot complete until shareholders approve it. The company remains suspended, and ASX has not agreed that the proposed funding package will be enough for reinstatement.

Advanced Engineered Materials is forecasting a sharp lift in second-half sales as its Quebec high-purity alumina operation moves from qualification work towards commercial production. The larger prize is a possible 6,000-tonne-per-year expansion, but that plan still depends on feasibility, financing and final investment approval.